
Gene-Silencing Technique Targets Scarring
• http://www.technologyreview.com, Susan YoungMassachusetts-based RXi Pharmaceuticals has developed a chemically modified version of the small interfering RNAs that drive the biochemical process of RNA interference, or RNAi.